- Home
- UPST vs RGC Comparison
UPST vs RGC Comparison
Compare UPST & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPST
- RGC
- Stock Information
- Founded
- UPST 2012
- RGC 2014
- Country
- UPST United States
- RGC Hong Kong
- Employees
- UPST N/A
- RGC N/A
- Industry
- UPST Finance: Consumer Services
- RGC Medicinal Chemicals and Botanical Products
- Sector
- UPST Finance
- RGC Health Care
- Exchange
- UPST Nasdaq
- RGC Nasdaq
- Market Cap
- UPST 5.5B
- RGC 6.6B
- IPO Year
- UPST 2020
- RGC 2021
- Fundamental
- Price
- UPST $67.17
- RGC $14.31
- Analyst Decision
- UPST Buy
- RGC
- Analyst Count
- UPST 15
- RGC 0
- Target Price
- UPST $74.04
- RGC N/A
- AVG Volume (30 Days)
- UPST 6.5M
- RGC 275.9K
- Earning Date
- UPST 11-06-2025
- RGC 10-24-2025
- Dividend Yield
- UPST N/A
- RGC N/A
- EPS Growth
- UPST N/A
- RGC N/A
- EPS
- UPST N/A
- RGC N/A
- Revenue
- UPST $884,807,000.00
- RGC N/A
- Revenue This Year
- UPST $59.24
- RGC N/A
- Revenue Next Year
- UPST $26.99
- RGC N/A
- P/E Ratio
- UPST N/A
- RGC N/A
- Revenue Growth
- UPST 53.62
- RGC N/A
- 52 Week Low
- UPST $31.40
- RGC $0.09
- 52 Week High
- UPST $96.43
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- UPST 49.16
- RGC 52.49
- Support Level
- UPST $61.15
- RGC $13.06
- Resistance Level
- UPST $69.75
- RGC $15.25
- Average True Range (ATR)
- UPST 3.81
- RGC 1.11
- MACD
- UPST 0.01
- RGC 0.22
- Stochastic Oscillator
- UPST 38.68
- RGC 49.13
About UPST Upstart Holdings Inc.
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.